Current drug development and trial designs in neuro-oncology: report from the first American Society...
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
About this item
Full title
Author / Creator
Rahman, Rifaquat, MD , Polley, Mei-Yin C, PhD , Alder, Laura, MD , Brastianos, Priscilla K, MD , Anders, Carey K, Prof , Tawbi, Hussein A, Prof , Mehta, Minesh, Prof , Wen, Patrick Y, Prof , Geyer, Susan, PhD , de Groot, John, Prof , Zadeh, Gelareh, Prof , Piantadosi, Steven, Prof , Galanis, Evanthia, Prof and Khasraw, Mustafa, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummarySuccessful drug development for people with cancers of the CNS has been challenging. There are multiple barriers to successful drug development including biological factors, rarity of the disease, and ineffective use of clinical trials. Based upon a series of presentations at the First Central Nervous System Clinical Trials Conference hosted...
Alternative Titles
Full title
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
Authors, Artists and Contributors
Author / Creator
Polley, Mei-Yin C, PhD
Alder, Laura, MD
Brastianos, Priscilla K, MD
Anders, Carey K, Prof
Tawbi, Hussein A, Prof
Mehta, Minesh, Prof
Wen, Patrick Y, Prof
Geyer, Susan, PhD
de Groot, John, Prof
Zadeh, Gelareh, Prof
Piantadosi, Steven, Prof
Galanis, Evanthia, Prof
Khasraw, Mustafa, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10401610
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10401610
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(23)00005-0
